Frontline of ASCT in High-risk DLBCL
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Diffuse Large B Cell Lymphoma
Related studies linked through entity extraction aliases.
Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Decitabine and Anti-PD-1 in R/R DLBCL
- Status
- RECRUITING
- Phase
- PHASE2
Pro-miniCHOP-like Regimen for Treatment-naive Elderly Patients
- Status
- RECRUITING
- Phase
- NA
Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy
- Status
- RECRUITING
- Phase
- N/A
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Study of Anti-CD19 CAR NK Cells in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.
- Status
- TERMINATED
- Phase
- N/A
Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL
- Status
- RECRUITING
- Phase
- NA
The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
- Status
- RECRUITING
- Phase
- N/A